The results of that study reported that SNN decreased the total fecal BA level and increased the colonic nuclear BA receptor and FXR expression, suggesting that modulating BA concentration might be a novel strategy to protect against NASH [65]. Here, NR1H4 is linked to metabolic dysfunction-associated steatohepatitis.